Table 3.

Clinical presentation and histology results of patients with inflammatory bowel disease (IBD). Patient 3 had the first IBD disease episode (3a) prior to and a relapse (3b) after restarting etanercept.

PatientType of IBDAbdominal PainAspect of StoolFrequency of StoolWeight LossOther SymptomsEndoscopyPathology
1UC+D, B, M4/day2.8 kg in 3 moVomitingGrade II-III proctosigmoiditisColon: active infection, crypt abscess, changed architecture indicative of UC
2CD+D, B, M6/day4 kg in 1 moMore arthritis, Perianal abscessSkip lesionsIndeterminate, later CD
3aCD+D, B2–8/day5 kg in 3 moVomiting and fatigueNormalColon: UC or CD with inflammation, granulomas
3bCD++D6/dayNAAbdominal cramps, pancreatitisNA
4CD1/dayNoRaised ESR and CRP; erythema nodosumNAEsophagitis: with epitheloid cell reaction and isolated giant cells
Duodenitis: with microgranulomata
Colitis with epitheloid cell reaction
5CD+NANANANoNACD
6UC+D, B25/dayNoNoUlcers, terminal ilium normalColitis with crypt abscess and ulcers, no granulomas
7CD+D, B6/dayNoNoNACD
8CD+DNANoNANAOverall active CD with granulomas
9CD+D5/dayYesAnemiaCDCD
10CD+D3/dayYesUnknownNACD
11ID+D3/dayGrowth stop, 1 yrNoChronic inflammation; colitis with crypt abscess
12CD+D2/day6.5 kg in 3 moNoCDCD
13UC+D, B> 3 x/day6 kg in 7 moNoNAUC
  • D: diarrhea, B: blood, M: mucus, CD: Crohn’s disease; UC: ulcerative colitis; ID: indeterminate; NA: not available.